We are live on
!
Find out more
SCA
Sandy Cove Advisors Portfolio holdings
AUM
$400M
1-Year Est. Return
27.68%
This Fund
S&P 500
This Quarter
Est. Return
-1.99%
1 Year Est. Return
+27.68%
3 Year Est. Return
+77.99%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$249M
AUM Growth
-$5.69M
(-2.2%)
Cap. Flow
+$1.78M
Cap. Flow
% of AUM
0.72%
Top 10 Holdings %
Top 10 Hldgs %
56.87%
Holding
129
New
4
Increased
65
Reduced
36
Closed
9
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Berkshire Hathaway Class B
BRK.B
|
+$2.6M |
| 2 |
JPMorgan Ultra-Short Municipal Income ETF
JMST
|
+$697K |
| 3 |
Vanguard S&P 500 ETF
VOO
|
+$661K |
| 4 |
Invesco QQQ Trust
QQQ
|
+$550K |
| 5 |
iShares Core MSCI EAFE ETF
IEFA
|
+$433K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Palantir
PLTR
|
+$2.07M |
| 2 |
Revolution Medicines
RVMD
|
+$609K |
| 3 |
Vanguard Dividend Appreciation ETF
VIG
|
+$483K |
| 4 |
Vanguard Short-Term Bond ETF
BSV
|
+$389K |
| 5 |
Broadcom
AVGO
|
+$321K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 10.62% |
| 2 | Financials | 10.47% |
| 3 | Healthcare | 3.34% |
| 4 | Consumer Staples | 3.1% |
| 5 | Communication Services | 2.99% |
Similar funds
DBIA
MAG
JGCM
BLC
KHCM
AIM
SFCL
PNFS
Sandy Cove Advisors's Q1 2025 Portfolio in Review
As of Q1 2025, Sandy Cove Advisors held 129 positions worth $249M, down 2.2% from $255M the previous quarter. Its ten largest holdings account for 57% of the portfolio.
Sandy Cove Advisors's Q1 2025 filing shows 4 new, 65 increased, 36 reduced and 9 closed positions. Its largest new stake was Vanguard Short-Term Corporate Bond ETF: 5,286 shares worth $417K. The largest sale was Palantir, an estimated $2.07M.
By sector, the portfolio is most concentrated in Technology at 11% of assets, down from 13% a quarter earlier, followed by Financials and Healthcare.
- Sandy Cove Advisors's largest Q1 2025 buy was Vanguard Short-Term Corporate Bond ETF: 5,286 shares worth $417K.
- Sandy Cove Advisors added most to Berkshire Hathaway Class B in Q1 2025, an estimated $2.6M increase.
- Sandy Cove Advisors's biggest Q1 2025 reduction was Revolution Medicines, cutting an estimated $609K.
- Sandy Cove Advisors fully exited Palantir in Q1 2025, selling an estimated $2.07M.
- Sandy Cove Advisors's ten largest holdings make up 57% of its $249M portfolio in Q1 2025.
- Sandy Cove Advisors opened 4 new positions and closed 9 in Q1 2025.
- Sandy Cove Advisors's portfolio value fell 2.2% quarter-over-quarter to $249M.
Based on Sandy Cove Advisors's 13F filing for Q1 2025, filed 12 May 2025.